![]() TRACON Pharmaceuticals TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration. | |||
Founding Date | Founding Date 2006 | Founding Date 1994 | Founding Date 2006 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Helsinki, FI HQ | Locations Alameda, US HQ | Locations San Diego, US HQ |
Employees | Employees 8 | Employees 1,14712% decrease | Employees 268% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 8.2 b | Valuation ($) 279.4 k |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $2.3b (FY, 2025) | Revenue (est.) $12m (FY, 2023) |
Net income | Net income N/A | Net income $782.6m (FY, 2025) | Net income ($3.6m) (FY, 2023) |
Funding | |||
Total funding raised | Total funding raised $ 10.6m | Total funding raised N/A | Total funding raised $ 41m |

Exelixis is an oncology company that develops cancer treatments.
View company
TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration.
View company